Boston, MA -- (SBWIRE) -- 04/20/2016 -- This report provides all the information you require to better understand PDL BioPharma and its partnering interests and activities since 2010.

The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies.

On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data.

The report will be delivered in PDF format within 1 working day of receipt of order.

One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Get More Details on this Report and a Full Table of Contents at PDL BioPharma Partnering Deals and Alliances 2010 to 2016

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives.

The initial chapters of this report provide an orientation of deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&A deals since 2010 to present date based on headline value.

Chapter 4 provides details on how to approach biopharma companies with partnering opportunities whilst chapter 5 lists forthcoming partnering events and conferences where biopharma companies will be present to discuss opportunities face to face.

The main body of the report is provided in chapter 6 providing a infographic visual summary of the company?s partnering activity since 2010 according to deal type, industry sector, phase of development, and therapy area.

The deals are listed by deal type, stage of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the deal record at the Current Agreements deals and alliances database. Where available, deal records also include the contract document as disclosed at the SEC.

One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of prospective partners' negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered ? contract documents provide this insight where press releases and databases do not.

In addition, contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Each contract document is accessible through a link to an online version of the actual contract document as filed with the Securities Exchange Commission. Analyzing actual company agreements allows assessment of the following:

-What is actually granted by the agreement to the partner company?
-What exclusivity is granted?
-What is the payment structure for the deal?
-How are sales and payments audited?
-What is the deal term?
-How are the key terms of the agreement defined?
-How are IPRs handled and owned?
-Who is responsible for commercialization?
-Who is responsible for development, supply, and manufacture?
-How is confidentiality and publication managed?
-How are disputes to be resolved?
-Under what conditions can the deal be terminated?
-What happens when there is a change of ownership?
-What sublicensing and sub-contracting provisions have been agreed?
-Which boilerplate clauses does the company insist upon?
-Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
-Which jurisdiction does the company insist upon for agreement law?

Partnering Deals and Alliances since 2010 report provides the user with the following key benefits:

Partnering interests and therapy focus revealed
Partnering activity since 2010 ? number of deals per year
Partnering activity for 2010-present
Activity by deal type
Activity by phase of development
Activity by therapeutic area
List of recent partner companies
Detailed listing of all partnering deals since 2010
Comprehensive access to actual contracts entered into by the company and its partners*
Insight into the terms included in a partnering agreement

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Array Biopharma Partnering Deals and Alliances 2010 to 2016
-Shire Partnering Deals and Alliances 2010 to 2016
-Vertex Partnering Deals and Alliances 2010 to 2016
-Allergan Partnering Deals and Alliances 2010 to 2016
-Acorda Therapeutics Partnering Deals and Alliances 2010 to 2016